A second Covid-19 vaccine has shown to be almost 95% effective.
US company Moderna plans to apply for approval for its vaccine in the coming weeks.
Just a week after Pfizer and BioNTech said their vaccine was over 90% effective, Moderna has published an early analysis of it's trial.
30,000 participants in the US were given two doses of either the vaccine or a placebo four weeks apart.
Confidence
Of the first 95 people to develop Covid symptoms, just 5 had been given the vaccine, which means it is 94.5% effective.
The news will add to the confidence that a vaccine can help end the pandemic.
We just announced that mRNA-1273, our COVID-19 vaccine candidate, has met its primary efficacy endpoint in the first interim analysis of the Phase 3 COVE study.
Read more: https://t.co/vYWEy8CKCv pic.twitter.com/YuLubU1tlx— Moderna (@moderna_tx) November 16, 2020
It comes at a time when Ireland is experiencing a worrying development.
The 5 day moving average has began to persistently increase.
The average daily number of cases is now 413 compared to 380 just 5 days ago.
